CRC has an immunosuppressive TME which stops the development of a highly effective response to ICB therapies. There's So an urgent must detect the means reprogram this suppressive TME in order to improve immunotherapy efficacy. In The existing review, we used CRISPR KO screens to discover genes that sensitize CRC https://stephenqwafh.blognody.com/28179245/the-single-best-strategy-to-use-for-rosthornin-a